We have 80 years experience in the field of complex and high value generic pharmaceutical products.


The safety and effectiveness of our pharmaceutical products are our symbol of quality.


Our production plant and quality control and development laboratories have the most advanced technologies.

Probirase®: Increased accessibility with high quality to the treatment of hepatitis C

Laboratorios Richmond launches Probirase®, the first Sofosbuvir generic in the region, the drug which, combined with others, has high proven Hepatitis C cure rates.

Read more +

Andes study: the possibility of treating HIV with only one pill

Estudio Andes

Richmond Labs, in coordination with Huesped Foundation, launched an innovative project that aims to analyze and study the efficacy and security of the mixture of two different drugs.

A new and innovative cardiovascular polypill arrives to Argentina


During the course of the 41st Argentine Congress of Cardiology, held through the 15th and 17th of October 2015 in La Rural, Laboratorios Richmond will be launching to the national market the first polypill ever to be produced for secondary prevention of cardiovascular disease.

Specialists discussed about the new drugs against HIV

El Dr. Cahn junto a Juan Manuel Artola, Marcelo Figueiras y Elvira Zini

On Thursday, August 6, Laboratorios Richmond sponsored together with Fundación Helios Salud and Fundación Huésped a Round Table in La Rural about the topic "What's new with the new drugs against the HIV virus?".